SEC Form DFiling only, no announcement found
Trellis Bioscience, based in Redwood City, CA, reported $9,093,000 sold in a private offering of equity and Series C Interests, with the first sale on January 30, 2026, in a Form D filed with the SEC on October 29, 2026. The filing says 16 investors have already invested. The total offering is stated as Indefinite.
Legal name on the filing: Trellis Bioscience, Inc.. Formerly TRELLIS BIOSCIENCE LLC, TRELLIS BIOSCIENCE INC.
| Amount sold | $9,093,000Basis: Form D total amount sold, as of the filing of October 29, 2026. Not the announced round size. |
|---|---|
| Total offering | IndefiniteThe most the company may sell under this offering. Not money raised. |
| Securities offered | Equity; Other (Series C Interests) |
| Exemption claimed | Rule 506(b) |
| Date of first sale | January 30, 2026 |
| Investors already invested | 16 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Biotechnology |
| Principal place of business | Redwood City, CA |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | over five years ago |
| Revenue range | Decline to Disclose |
| SEC CIK | 1162015 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Nora Mende | Executive OfficerChief Financial Officer | None linked |
| Larry Kauvar | Executive OfficerChief Science Officer | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Oct 29, 2026 | D/A (amendment) | $9,093,000 | Indefinite |
The latest filing states the current amount sold; an amendment replaces the figure before it.
From the issuer's EDGAR filing history. Amounts are shown for filings in our warehouse, which holds operating-company filings from July 16, 2026.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through October 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Trellis Bioscience: SEC Form D deal record", https://vcbeast.com/deals/trellis-bioscience-form-d-2026-01-30. Source: SEC EDGAR, accession 0000929638-26-004073.